Cyclobenzaprine Hydrochloride
Product Images NDC 53002-3080

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 53002-3080). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (7d5e3bad 7f85 4e2b 81c5 7981c456e45f 01)

Chemical structure of Cyclobenzaprine Hydrochloride depicted as a molecular diagram with aromatic rings and associated chemical groups.*

FDA Label Image

Image (7d5e3bad 7f85 4e2b 81c5 7981c456e45f 02)

A data table comparing the incidence percentages of drowsiness, dry mouth, fatigue, and headache among three groups: Cyclobenzaprine HCl Tablets 5 mg (N=464), Cyclobenzaprine HCl Tablets 10 mg (N=249), and Placebo (N=469). It shows higher rates of drowsiness and dry mouth with the Cyclobenzaprine tablets than placebo.*

FDA Label Image

Image (7d5e3bad 7f85 4e2b 81c5 7981c456e45f 03)

A data table comparing adverse effects reported in clinical studies and a surveillance program for Cyclobenzaprine Hydrochloride Tablets, 10 mg. It lists percentages for drowsiness, dry mouth, and dizziness under each study type.*

FDA Label Image

Label Image (Lbl530023080)

Cyclobenzaprine Hydrochloride 10 mg tablets packaging label from RPK Pharmaceuticals, Inc. The label states the product contains 30 tablets, with directions to take 1 tablet 3 times a day as needed or directed. Contains warnings about muscle relaxant use, and notes the active ingredient amount as 10 mg per tablet. Includes lot numbers, expiration dates, and barcode on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.